These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8521882)

  • 41. Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity.
    Choi JY; Lee KH; Hong KP; Kim BT; Seo JD; Lee WR; Lee SH
    J Nucl Cardiol; 2001; 8(1):4-9. PubMed ID: 11182704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial.
    Basu S; Senior R; Raval U; van der Does R; Bruckner T; Lahiri A
    Circulation; 1997 Jul; 96(1):183-91. PubMed ID: 9236433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
    Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple action compounds in angina pectoris.
    Kelly DT; Freedman SB
    Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
    Park K; Park TH
    Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P; Broadhurst P; Lahiri A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure.
    Maurer MS; Sackner-Bernstein JD; El-Khoury Rumbarger L; Yushak M; King DL; Burkhoff D
    Circ Heart Fail; 2009 May; 2(3):189-96. PubMed ID: 19808339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis.
    Schleman KA; Lindenfeld JA; Lowes BD; Bristow MR; Ferguson D; Wolfel EE; Abraham WT; Zisman LS
    J Card Fail; 2001 Mar; 7(1):4-12. PubMed ID: 11264544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
    van der Does R; Eberhardt R; Derr I; Ehmer B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
    Senior R; Basu S; Kinsey C; Schaeffer S; Lahiri A
    Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers.
    Lindenfeld J; Robertson AD; Lowes BD; Bristow MR;
    J Am Coll Cardiol; 2001 Dec; 38(7):1950-6. PubMed ID: 11738299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of carvedilol on right ventricular function in chronic heart failure.
    Quaife RA; Christian PE; Gilbert EM; Datz FL; Volkman K; Bristow MR
    Am J Cardiol; 1998 Jan; 81(2):247-50. PubMed ID: 9591916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carvedilol in the treatment of chronic heart failure.
    Moe G
    Expert Opin Pharmacother; 2001 May; 2(5):831-43. PubMed ID: 11336626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The carvedilol hibernation reversible ischaemia trial; marker of success (CHRISTMAS). The CHRISTMAS Study Steering Committee and Investigators.
    Cleland JG; Pennel D; Ray S; Murray G; MacFarlane P; Cowley A; Coats A; Lahiri A
    Eur J Heart Fail; 1999 Jun; 1(2):191-6. PubMed ID: 10937930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Severe heart failure--effects of carvedilol therapy. The Copernicus Study].
    Kindermann M; Böhm M
    Internist (Berl); 2002 Feb; 43(2):284-6. PubMed ID: 11963765
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure.
    Lou YF; Shi XP; Tong H; Yu GY; Yao GD; Dong K
    Circ J; 2009 Dec; 73(12):2363; author reply 2364. PubMed ID: 19940373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.